By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



6F, No. 6, Sec. 1, Jung-Shing Road
Wugu Shiang
Taipei      Taiwan
Phone: 02-8976-9628 Fax: 02-8976-95629



Company News
CytoPharm and Amarillo Biosciences (AMAR) Announce Positive HCV Study Results: Oral Interferon Found to Reverse Thrombocytopenia; Reduced Relapse Rate Seen in Patients With Mild Fibrosis 6/15/2012 7:50:48 AM
Amarillo Biosciences (AMAR) and CytoPharm Announce Start of Enrollment for Hepatitis C Study in Taiwan 6/29/2009 10:59:20 AM
Amarillo Biosciences (AMAR) Partner CytoPharm Approved to Enroll 165 Patient Phase 2 Hepatitis C Trial in Taiwan 2/13/2009 9:52:49 AM
Amarillo Biosciences (AMAR) Signs Deal with CytoPharm of Taiwan 3/25/2008 1:28:38 PM
Amarillo Biosciences (AMAR) Enters Into a License and Supply Agreement With CytoPharm for Low Dose Oral Interferon Use in Animal Diseases in China and Taiwan 3/25/2008 9:56:34 AM
Amarillo Biosciences (AMAR) Partner, CytoPharm, to Conduct 144 Patient Phase 2 Hepatitis C Trial in Taiwan 2/19/2008 10:16:07 AM
CytoPharm to Conduct Hepatitis C Trial and Seek Regulatory Approval for Amarillo Biosciences (AMAR)' Low Dose Oral Interferon 5/31/2007 1:05:33 PM